Dr. Loren Walensky, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute discusses the biology of cell death and how a new chemical technology is yielding a host of new tools to study and treat diseases, like cancer, that are characterized by an imbalance of cellular life and death.
Peptide Stapling: A Novel Approach to Cancer Drug Development
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Loren Walensky, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute discusses the biology of cell death and how a new chemical technology is yielding a host of new tools to study and treat diseases, like cancer, that are characterized by an imbalance of cellular life and death.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?